Sight Sciences to earn $34M from Alcon patent infringement suit
Sight Sciences announced today that it received a jury trial verdict awarding it $34 million from a patent infringement case against Alcon.
Source: massdevice.com
📰 Sight Sciences Nasdaq News
Sight Sciences Nasdaq News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sight Sciences Nasdaq. Real-time updates on events, politics, business and more.
Sight Sciences closes $65M credit facility
Sight Sciences (Nasdaq:SGHT) announced that it closed a senior secured credit facility worth up to $65 million.
Source: massdevice.com
5 top ophthalmic device innovations you need to know
Innovation finds its way into all areas of medtech, and ophthalmic treatments represent another burgeoning space.
Clareon Monofocal Acuvue Oasys Max Acuvue Theravision Prix Galien International Sight Sciences Sight Sciences Nasdaq
Source: massdevice.com